Sitagliptin, a DPP-4 inhibitor, administered once- or twice-daily, provides substantial improvement in 24-hour glucose control in Japanese patients with type 2 diabetes mellitus (T2DM)

被引：0
|
作者：
Nonaka, Kenji
Tsubouchi, Hiroshi
Okuyama, Kotoba
Fukao, Yukako
Stein, Peter P.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A540 / A540
页数：1
相关论文
共 50 条
  • [1] Sitagliptin, a DPP-4 inhibitor, administered once- or twice-daily, provides improvement throughout 24-hour glucose control in Japanese patients with type 2 diabetes mellitus
    Nonaka, K.
    Tsubouchi, H.
    Okuyama, K.
    Fukao, Y.
    Stein, P. P.
    DIABETOLOGIA, 2007, 50 : S365 - S366
  • [2] Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin
    Forst, Thomas
    Bramlage, Peter
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1299 - 1313
  • [3] Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes
    Phillips, LS
    Grunberger, G
    Miller, E
    Patwardhan, R
    Rappaport, EB
    Salzman, A
    DIABETES CARE, 2001, 24 (02) : 308 - 315
  • [4] Efficacy of Concomitant Therapy in Japanese Type 2 Diabetes Mellitus Patients With Insulin and Sitagliptin, a DPP-4 Inhibitor
    Nakagami, Tomoko
    Ide, Risa
    Iwasaki, Naoko
    Ogata, Makiko
    Oya, Junko
    Osawa, Mari
    Tanaka, Nobue
    Takaike, Hiroko
    Sato, Asako
    Miura, Junnosuke
    Uchigata, Yasuko
    DIABETES, 2013, 62 : A298 - A298
  • [5] Omarigliptin, a once-weekly DPP-4 inhibitor, provides similar glycaemic control to sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on metformin
    Gantz, I.
    Lai, E.
    Suryawanshi, S.
    Andryuk, P.
    Engel, S. S.
    DIABETOLOGIA, 2015, 58 : S54 - S55
  • [6] Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes (vol 24, pg 308, 2001)
    Phillips, LS
    Grunberger, G
    Miller, E
    Patwardhan, R
    Rappaport, EB
    Salzman, A
    DIABETES CARE, 2001, 24 (05) : 973 - 973
  • [7] Effects of Once-daily Sitagliptin on 24-h Glucose Control Following 4 Weeks of Treatment in Japanese Patients with Type 2 Diabetes Mellitus
    Nonaka, K.
    Tsubouchi, H.
    Okuyama, K.
    Fukao, Y.
    Johnson-Levonas, A. O.
    Amatruda, J. M.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (03) : 232 - 237
  • [8] The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial
    Linjawi, Sultan
    Sothiratnam, Radhakrishna
    Sari, Ramazan
    Andersen, Henning
    Hiort, Line Conradsen
    Rao, Paturi
    PRIMARY CARE DIABETES, 2015, 9 (05) : 370 - 376
  • [9] The DPP-4 inhibitor, LAF237, improves glycemic control in patients with type 2 diabetes (T2DM) inadequately treated with metformin
    Ahren, B
    Gomis, R
    Mills, D
    Schweizer, A
    DIABETES, 2004, 53 : A83 - A83
  • [10] Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus
    Katsuno, Tomoyuki
    Ikeda, Hiroki
    Ida, Kenichi
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    ENDOCRINE JOURNAL, 2013, 60 (06) : 733 - 742
12345